Genomic projects exploit scale as clinical applications play catch-up
New studies on gene signatures and chromosomal instability using samples from large databases add insight to their clinical applicability.
By
Precision and Personalized Medicine
Latest in
Precision and Personalized Medicine
Longevity technology and its future
Despite developments, epigenetic clocks and similar longevity technologies remain expensive.
By
3D printing in drug manufacturing: unlocking future possibilities
From personalised medicine to the democratisation of drug access, XIL Health founder and CEO Susan Lang believes 3D printing can…
By
Approach to spur testosterone production instead of synthesis on the horizon
Current treatments for hypogonadism involve synthetic hormones or steroids which come with side effects and high abuse potential.
By
ICON Q&A: talking affordability in cell and gene therapies
ICON’s Tamie Joeckel discusses the challenges of making cell and gene therapies affordable for payers and patients alike.
By
The reality of optimising real-world data
Researchers and pharma companies must harness the potential of real-world data to optimise rare disease drug discovery and development.
By
Adaptimmune Q&A: an alternative approach to T-cell cancer therapies
Adaptimmune’s chief business officer discusses the company’s T-cell research, and its hopes for a new partnership with Roche.
By
Regenerative medicine: ready for the big leagues?
What is at the cutting-edge of regenerative medicine in 2021, and are these complex products ready to break into the…
By